Related Experiment Video

Updated: Jun 15, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.4K

Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor

Harika Nagandla1, Christoforos Thomas1

  • 1Houston Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA.

Receptors (Basel, Switzerland)
|August 23, 2024
PubMed

Insights

Estrogen receptor beta (ERβ) may suppress tumors in breast cancer, unlike the oncogenic ERα. New research using advanced models and ligands reveals ERβ

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Estrogen receptor alpha (ERα) is a validated biomarker and therapeutic target in breast cancer.
  • Estrogen receptor beta (ERβ) was discovered in 1996, expanding the understanding of estrogen signaling.
  • ERβ is proposed to have tumor-suppressive functions in breast cancer, contrasting with ERα's oncogenic role.

Purpose of the Study:

  • To review recent advancements in understanding Estrogen receptor beta (ERβ) biology.
  • To elucidate the mechanism of action and clinical significance of ERβ in breast cancer.
  • To highlight new findings from transgenic models and specific synthetic ligands.

Main Methods:

  • Utilized new transgenic models to study ERβ effects in normal and malignant breast tissues.
  • Employed highly specific synthetic ligands to investigate ERβ-mediated gene regulation.
  • Synthesized recent research findings on ERβ biology and clinical relevance.

Main Results:

  • New transgenic models have revealed previously undetected effects of ERβ in breast tissues.
  • Specific synthetic ligands have demonstrated distinct ERβ gene regulation mechanisms in cancer.
  • Significant new information regarding ERβ's biological activities and clinical importance is now available.

Conclusions:

  • ERβ plays a distinct role in breast cancer, potentially as a tumor suppressor.
  • Ongoing research is crucial for fully understanding ERβ's functions and therapeutic potential.
  • Recent advancements provide a deeper insight into the biology and clinical implications of ERβ.
Keywords:
ERβERβ ligandsbreast cancertumor microenvironmenttumor progression

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.2K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K